Overall, MYC is believed to be dysregulated in approximately 70% of cancers [5] Deregulation is mediated by multiple different mechanisms including gene amplification, gene translocation, altered methylation and enhanced intracellular signaling [6–8]. This evidence concerns the gene MYC and cancer.